Health

Pelthos Therapeutics Announces CFO Transition

Senior Vice President, Finance & Accounting John M. Gay named Chief Financial Officer April 10, 2026 17:00 ET  | Source:…

2 months ago

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy – CORRECTION

April 10, 2026 16:09 ET  | Source: Mesoblast Limited Working with Parent Project Muscular Dystrophy and the Duchenne Registry on…

2 months ago

BioNTech and DualityBios Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of heavily pre-treated…

2 months ago

NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification

Largo, FL, April 10, 2026 (GLOBE NEWSWIRE) -- A commission may be earned if you purchase through links in this…

2 months ago

Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency

Los Angeles, CA, April 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not…

2 months ago

IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information

Miami, FL, April 10, 2026 (GLOBE NEWSWIRE) -- Affiliate Disclosure: This article contains affiliate links. If readers purchase through these…

2 months ago

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

Cheyenne, WY, April 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute…

2 months ago

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

April 10, 2026 17:02 ET  | Source: Replimune, Inc. WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…

2 months ago

TRICARE Now Covers Online Therapy in New York $0 Copay for Active-Duty Families Through MMHC

Manhattan Mental Health Counseling becomes an in-network TRICARE provider for New York, accepting TRICARE Select and Reserve Select for virtual…

2 months ago

Best ACV Gummies Claims Evaluated: What Ingredient Labels Actually Disclose vs. What Marketing Pages Emphasize 2026 Consumer Transparency Update

Largo, FL, April 09, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through these…

2 months ago